Those who enter a GLP-1 treatment plan without a solid foundation of healthy habits may find it challenging to maintain their results once they discontinue the medication
These findings were further corroborated within the Lifelines Cohort, where results showed sex- and duration-specific DNA methylation changes in women exposed to intermediate-term NSW (10-16 years), enriched in pathways related to circadian regulation and cellular senescence
Retatrutide is still completing its phase 3 trial program, with FDA approval estimated for 2027 or 2028
The peaks at m/z values of 361.3 and 363.3 originated from deuterium and tritium substituted dityrosine molecules
For commercial plan sponsors, pharmacy benefit spending grew by 4.0%
Key benefits, including ingredients, effectiveness, and versatility